VANCOUVER, Sept. 10, 2015 /PRNewswire/ -- Howe Sound Research announces today the release of their latest research report "LIQUID BIOPSY MARKETS - Global Market Size, Strategies and Forecasts 2015 to 2020."
"Cancer screening through liquid biopsy is by far the largest market opportunity we have seen in the Clinical Diagnostics space. A simple blood test will be able to determine whether or not you have a certain type of cancer. It will identify the cancer genetically to give a much more accurate picture than can be had by looking at it through a microscope. This is a game changer in cancer treatment," says Greg Powell, President.
The report includes detailed breakouts for 15 countries and 4 regions along with breakouts for Lung, Breast, Colorectal, Prostate and Other Cancers. "The technology will displace expensive and invasive surgical biopsy, but it will likely usher in an era of routine screening for cancer, initially starting with high risk individuals. Smokers, for instance, could undergo regular screening tests for lung cancer by giving a sample of their blood in their doctor's office. The report looks at the three roles of these blood tests: detection, treatment and screening. Liquid biopsy not only helps with detection but it improves the way cancer is treated. Doctors get accurate real time feedback on how well a particular type of therapy is working. Even better they can track how the cancer mutates in response to the chosen treatment. All of this is achieved without repetitive surgeries," notes Mr. Powell.
The report looks at issues affecting the market as the technology moves from the laboratory into clinical use over the next five years. "Tests are initially expensive but Next Generation Sequencing technology will help drive down costs. President Obama's Personalized Medicine initiative will also speed market development," explains Mr. Powell. A big issue is how fast regulators can respond to the wide range of tests coming out of laboratories all over the world. The report looks at a phased approach to market growth depending on the speed with which the technology gains acceptance in a clinical setting.
"We think that the initially high cost of these tests will decline and open up the market even faster. In some segments we foresee growth rates in excess of 100% per year," says Mr. Powell. In addition to market forecasts the report looks at the potential market sizes, by country, by different types of cancer and by detection, management and screening opportunities.
The report, LIQUID BIOPSY MARKETS, is available for immediate download with a wide range of licensing options at http://www.howesoundresearch.com/products/liquid-biopsy-markets-global-market-size-strategies-and-forecasts-2015-to-2020
For more information contact: Andrea Hardaker, Research Manager at firstname.lastname@example.org
Contact: Greg Powell
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-report-outlines-new-multibillion-dollar-market-for-cancer-testing-300140607.html
SOURCE Howe Sound Research